Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Independent Respiratory Services (IRS) is a leading provider of respiratory home care services and medical equipment in British Columbia, Canada. Founded in 1996, the company specializes in the clinical assessment and treatment of sleep-disordered breathing, particularly obstructive sleep apnea, as well as the provision of home oxygen therapy. Their service model includes community-based clinics that offer level 3 sleep studies, CPAP therapy management, and the supply of medical-grade oxygen concentrators. IRS operates a comprehensive network across the province to support patients with chronic respiratory conditions through personalized care and equipment maintenance. In 2016, the company was acquired by Air Liquide Healthcare's Canadian subsidiary, VitalAire, though it continues to operate under its established brand name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Independent Respiratory Services.